Gelfand JM

Migraine is a common comorbidity in patients with sarcoidosis, according to a recent study. As such, better recognition and targeted treatment of migraine has the potential to improve quality of life as part of a comprehensive care plan for those with sarcoidosis. The ID Migraine questionnaire was administered to a well-phenotyped observational cohort of patients with sarcoidosis (most of whom were seeking specialty care) and healthy controls. Predictors of migraine status were examined using univariate and multivariable logistic regression. Researchers found:

• Migraine was seen in 29% of 96 patients with sarcoidosis and 13% of 39 healthy controls.
• Among those with sarcoidosis, in univariate regression analysis only female sex was predictive of having migraine, and in a multivariable regression female sex remained significant.

There was no association between migraine and age, depression, dyspnea, immunosuppression use, or erythrocyte sedimentation rate.

Migraine is common in patients with sarcoidosis. [Published online ahead of print March 26, 2018]. Cephalalgia. doi:10.1177/0333102418768037.

Migraine is a common comorbidity in patients with sarcoidosis, according to a recent study. As such, better recognition and targeted treatment of migraine has the potential to improve quality of life as part of a comprehensive care plan for those with sarcoidosis. The ID Migraine questionnaire was administered to a well-phenotyped observational cohort of patients with sarcoidosis (most of whom were seeking specialty care) and healthy controls. Predictors of migraine status were examined using univariate and multivariable logistic regression. Researchers found:

• Migraine was seen in 29% of 96 patients with sarcoidosis and 13% of 39 healthy controls.
• Among those with sarcoidosis, in univariate regression analysis only female sex was predictive of having migraine, and in a multivariable regression female sex remained significant.

There was no association between migraine and age, depression, dyspnea, immunosuppression use, or erythrocyte sedimentation rate.

Migraine is common in patients with sarcoidosis. [Published online ahead of print March 26, 2018]. Cephalalgia. doi:10.1177/0333102418768037.

Migraine is a common comorbidity in patients with sarcoidosis, according to a recent study. As such, better recognition and targeted treatment of migraine has the potential to improve quality of life as part of a comprehensive care plan for those with sarcoidosis. The ID Migraine questionnaire was administered to a well-phenotyped observational cohort of patients with sarcoidosis (most of whom were seeking specialty care) and healthy controls. Predictors of migraine status were examined using univariate and multivariable logistic regression. Researchers found:

• Migraine was seen in 29% of 96 patients with sarcoidosis and 13% of 39 healthy controls.
• Among those with sarcoidosis, in univariate regression analysis only female sex was predictive of having migraine, and in a multivariable regression female sex remained significant.

There was no association between migraine and age, depression, dyspnea, immunosuppression use, or erythrocyte sedimentation rate.

Migraine is common in patients with sarcoidosis. [Published online ahead of print March 26, 2018]. Cephalalgia. doi:10.1177/0333102418768037.